Cholestech Counting On GDX Diabetes Test To Drive Lipid System Sales
This article was originally published in The Gray Sheet
Executive Summary
Cholestech will attempt to boost sales of its LDX lipid management system by co-promoting the product with the GDX glycated hemoglobin test through February
You may also be interested in...
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
The Senate will take up Medicare contractor and inpatient prospective payment reform proposals within the "Medicare Modernization and Prescription Drug Act" of 2002 (HR 4954) after the July 4 recess
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.